Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
1
20%
Ph phase_3
1
20%
Ph phase_2
2
40%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
unknown1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)

Trials by Status

completed240%
unknown120%
terminated120%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
unknownphase_3

Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

NCT00863226
completed

Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

NCT00862537
withdrawnphase_2

Low Level Magnetic Fields for the Treatment of Osteoarthritis of the Hip

NCT01312285
terminatedphase_2

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

NCT00982293
completedphase_1

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

NCT00863954

Clinical Trials (5)

Showing 5 of 5 trials
NCT00863226Phase 3

Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

Unknown
NCT00862537

Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

Completed
NCT01312285Phase 2

Low Level Magnetic Fields for the Treatment of Osteoarthritis of the Hip

Withdrawn
NCT00982293Phase 2

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Terminated
NCT00863954Phase 1

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5